Clinical Trial Update: A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a treatment of idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: UNKNOWN